Cost-effectiveness of Clinical Pathway in Coronary Artery Bypass Surgery by Lin,  Y.K. et al.
ORIGINAL PAPER
Cost-effectiveness of Clinical Pathway in Coronary Artery
Bypass Surgery
Yung-Kai Lin & Chia-Pin Chen & Wen-Chen Tsai &
Yu-Ching Chiao & Blossom Yen-Ju Lin
Received: 24 April 2009 /Accepted: 27 July 2009 /Published online: 13 August 2009
# Springer Science + Business Media, LLC 2009
Abstract Few studies have been devoted to the exploration
of the effect of clinical pathways on coronary artery diseases
treated with coronary artery bypass (CAB) surgery. This study
was aimed to investigate the cost and effectiveness of the
clinical pathway on CAB surgery in a medical center. With a
retrospective dataset in 2003–2007, 212 CAB surgery patients
were included. Data of the costs and postoperative complica-
tion occurrence and length of stays were the focus and patient
demographics, surgical risk indicator EuroSCORE, surgical
conditions were collected. It revealed that there was differen-
tiation across specified cost items in beating heart CAB
surgery patients, but not for heart arrest CAB surgery patients
with and without clinical pathways enrolled. In addition, there
was no difference in postoperative complication occurrence in
CAB surgery patients enrolled into clinical pathways.
However, robotic beating heart CAB surgery patients enrolled
clinical pathways were shown to have less postoperative
ordinary ward stay than those not enrolled clinical pathways.
CAB surgery patients’ age and surgical risks were related to
their postoperative lengths of stay to some extent.
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Introduction
The standardization of clinical practice is viewed as a way for
reducing the length of stay as well as hospital charges, while
maintaining quality of medical care. Approaches have ranged
from using general sets of principles called practice guide-
lines using specific and detailed outlines for care called
clinical pathways [1–3]. In the medical field, clinical
pathways have been applied worldwide to the clinical care
in surgeries, medical care, and rehabilitation. In particular,
cardiovascular treatment is an area in which clinical path-
ways have been embraced, due to the high cost associated
with cardiovascular diseases and procedures [4–6].
Various results of implementing clinical pathways in
surgeries have been found in the evidence-based health care
researches. For example, a retrospective study with 780
patients found that critical path group had a significant
decrease in hospitals and surgical lengths of stay [7]. A
retrospective cohort study from 1988 to 1998 in the
department of surgery of an academic medical center in
Maryland, USA, reveals that critical pathways may de-
crease postoperative stay for some, but not all, surgeries [8].
Furthermore, it was found that critical pathway programs
might have limited effectiveness, for example, pathway
effectiveness in reducing the length of stay tended to be
better for only lower patient severity of illness [8].
In the field of coronary artery bypass (CAB) surgery,
limited case studies in the certain hospital facilities have
been devoted to understand the effect of clinical pathways
in CAB surgery [9]. Within a university hospital in
Massachusetts, USA, it was pointed out the length of stay
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decreased for CAB surgery after implementing the clinical
pathways implemented; however, similar decreases were
shown in their neighboring hospitals that did not have
critical pathways or other specific efficiency initiatives [10].
Our study was aimed to investigate the cost and effective-
ness analyses of the implementation of the clinical pathway
on CAB surgery in a medical center in Taiwan. It was
expected to stimulate medical professionals to establish best
practice and advance the care of patients with coronary
artery diseases under CAB surgery.
Methods
Implementation of the clinical pathway of CAB surgery
in the medical center
Background
This study was conducted in one veteran general hospital
nationally accredited as one of the 14 medical centers in
Taiwan. It is located in the middle of Taiwan and owns
around 1,400 hospital beds. The average outpatient volume
is about 1,500,000 visits per year and the average inpatient
volume is 45,000 discharges per year in the period of 2000
to 2006. And seven cardiac surgeons perform about 450–
550 cardiac surgeries per year in the Cardiovascular
Department. The clinical pathway of CAB surgery has
been demonstrated in the Cardiovascular Department since
1999 and reviewed/revised annually. At this time, the cost
and effectiveness analyses were performed to evaluate the
feasibility and usefulness of CAB clinical pathway for
future implementation.
Design of the clinical pathway for CAB surgery
The clinical pathway for CAB surgery in the studied medical
center was formulated by a designer team, which consisted of
surgeons, nurse practitioners, pharmacists, rehabilitants, and
respiratory physicians/practitioners. In common with those
identified in the literature the clinical pathway was designed
to have clear daily goals in the admission course [6, 11–13].
These daily goals were listed on a checklist and they were
prinked by clinical physicians and nurse practitioners every
day. The comments and targeted outcomes of the clinical
pathway of CAB surgery were routinely revised based on
the data collection in the annual review meeting. Further-
more, all the revised items were checked monthly to confirm
the change being suitable for the patient’s safety and ethic
issue. The CAB clinical pathway in the studied medical
center is categorized into three parts, including preoperative
preparation, postoperative pathway, and rehabilitation (see
Appendix 1 for details).
Study subjects
Seven hundred and four patients administered by the CAB
surgery in the studied medical center in the period from
Jan 2003 to Dec 2007, with 574 patients (81.5%) as
elective surgeries and 130 patients (18.5%) as emergent
surgeries, were considered. Because the possible differ-
ences in preoperative length of stay, angiography, and
percutaneous coronary intervention might exist between
elective and non-elective CAB surgery patients in the
costs analyses [13], only the patients undergoing elective
CAB surgery were selected in this study. Furthermore,
those who died, were barely found the patient surgery
episode course and records, and were suffered from severe
complications (see Appendix 2) were excluded. Finally,
212 CAB surgery patients were included for the cost and
effectiveness analyses of CAB surgery clinical pathways
in this study.
Previous studies have shown that there might exist
different outcomes between conventional CAB surgery
(i.e., heart arrest) and off-pump CAB surgery (i.e., beating
heart) [13–16]. Furthermore, the medical center has
introduced robotic CAB surgery in these 5 years for beating
heart CAB surgeries. Therefore, the included 212 CAB
surgery patients could be divided into three major strat-
ifications, that is, patients with heart arrest CAB surgeries,
non-robotic beating heart CAB surgeries, and robotic
beating heart CAB surgeries. The included patient sample
treated entirely in the cardiovascular department was
undergone the implementation of CAB surgery clinical
pathways and those referred from other medical specialty
departments were not enrolled in the CAB surgery clinical
pathways (see Table 1).
Measurements
To understand the cost and effectiveness of clinical path-
ways for the CAB surgery patients, costs and postoperative
complication and length of stay (i.e., ICU stay and ordinary
ward stay) were measured in this study. The cost measure-
ments for CAB surgery patients included costs of visiting,
ICU wards, ordinary wards, examinations, radiology,
disposals, operation, anesthesia, specific medical materials
for operations, blood transfusion, and medication. Patient
demographics such as age [17–19], gender [20, 21] and
patient surgical risk indicator, EuroSCORE [22–25], were
collected. And the surgery relevant data such as the number
of surgical graft bypass [19] done in operation were also
traced. Patient demographics, surgical risk indicator (Euro-
SCORE), and the number of surgical graft bypass were
collected to adjust CAB surgery patients’ cost and
effectiveness comparisons for exploring the effect of the
implementation of clinical pathways.
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Data collection
This is a retrospective study with secondary data for
analysis. Medical records carried the demographic and
medical information for CAB surgery patients and the
hospital administrative dataset provided the cost infor-
mation for the individual CAB surgery patients. The
data acquisition was approved by the studied medical
center.
Statistical techniques
The data were first analyzed descriptively with means and
standard deviations calculated for continuous variables, and
frequency and percentages for categorical variables. The
univariate analyses including Wilcoxon W, ANOVA, and
Fisher’s exact tests, multiple regression analyses, and
logistic regressions were performed in this study, with
SPSS 12.0 and EXCEL software.
Table 1 Personal and medical backgrounds of CAB surgery patients in the preoperative, operative and postoperative stages
Total (n=212) Heart arrestb (n=48) Beating heartb (n=164)
CP enrolled
(n=25)
Non-CP enrolled
(n=23)
CP (non-robotic)
enrolled (n=65)
CP (robotic)
enrolled (n=41)
Non-CP enrolled
(n=58)
<Patient group 1> <Patient group 2> <Patient group 3> <Patient group 4> <Patient group 5>
Freq.
(mean)
%
(SD)
Freq.
(mean)
%
(SD)
Freq.
(mean)
%
(SD)
Freq.
(mean)
%
(SD)
Freq.
(mean)
%
(SD)
Freq.
(mean)
%
(SD)
Preoperative stage
Age (64.35) (10.52) (64.80) (10.75) (64.52) (9.95) (64.18) (10.77) (64.76) (11.64) (63.98) (9.85)
Gender
Female 40 19 7 28 5 22 13 20 5 12 10 17
Male 172 81 18 72 18 78 52 80 36 88 48 83
EuroSCORE (3.72) (2.26) (4.20) (2.48) (3.78) (2.15) (3.85) (2.18) (3.46) (2.70) (3.53) (1.98)
<6a 164 77 17 68 17 74 51 78 30 73 49 84
≥6 48 23 8 32 6 26 14 22 11 27 9 16
Enrolled clinical pathway
No 81 38
Yes 131 62
Operative stage
Operation procedure
Heart arrest 48 23 25 100 23 100 0 0 0 0 0 0
Beating heart
(non-robotic)
123 58 0 0 0 0 65 100 0 0 58 100
Beating heart (robotic) 41 19 0 0 0 0 0 0 41 100 0 0
Number of surgical graft
bypass
(3.08) (0.74) (3.04) (0.79) (3.26) (0.86) (3.02) (0.70) (3.00) (0.59) (3.17) (0.80)
Postoperative stages
Complicationc
No 23 92 21 91 61 94 39 95 53 91
Yes 2 8 2 9 4 6 2 5 5 9
Length of postoperative
stay (days)
ICU (2.61) (1.16) (2.80) (1.15) (2.87) (1.14) (2.38) (1.32) (2.56) (1.07) (2.71) (1.03)
Ordinary wardd (5.91) (2.48) (6.92) (2.31) (7.09) 4.16 (5.86) (1.52) (4.24) (1.59) (6.24) (2.54)
CP clinical pathway
a EuroSCORE <6 means patient with low risk for CAB surgery
b There is no testing difference for age, gender, EuroSCORE between CAB surgery patients enrolled in clinical pathway and not enrolled in
clinical pathway, within heart arrest group and beating heart group, respectively
c Fisher’s Exact Test, p>0.05 for heart arrest and beating heart CAB surgery patients, respectively, with and without clinical pathways
d ANOVA testing revealed that length of postoperative stay in ordinary wards were: patient group 3 & 5>patient group 4 (p<0.001)
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Results
Among the 212 studied CAB surgery cases studied, most
cases were male (81%), and with lower EuroSCORE (<6,
77%). The average patient age was 64 years old. Forty-
eight cases (22%) underwent heart arrest CAB surgery and
164 cases (78%) were administered with beating heart CAB
surgery. Of the 48 patients with heart arrest CAB surgeries,
25 cases (50%) were enrolled with clinical pathways. Of
the 164 patients with beating heart CAG surgeries, 106
cases (65%) were enrolled with clinical pathways.
There did not exist statistically significance in age,
gender, and EuroSCORE of heart arrest CAB surgery
patients and beating heart CAB surgery patients
respectively, with and without enrolled clinical path-
ways (p>0.05). In terms of medical backgrounds of CAB
surgery patients in the operative stage, the total 212 cases
studied went through three graft bypass surgeries on
average (see Table 1: column “Total”). Of the heart arrest
(i.e., patient group 1 and 2) and beating heart (i.e., patient
group 3, 4, and 5) CAB surgery patients, respectively, no
statistical significance in the number of graft bypass
surgeries was observed. Detailed information on the
personal and medical backgrounds of the CAB surgery
patients is shown in Table 1.
Cost analysis for heart arrest CAB surgery patients
Details of costs in the full course of disease treatment
were analyzed in patients who received heart arrest CAB
surgery with and without enrolling into the clinical
pathway (i.e., Patient Group 1 & 2) (Table 2). Overall,
surgery-related costs, including surgery operation, anes-
thesia, special medical materials (item 16) were the
largest costs in the heart arrest CAB surgery patients,
followed by ward costs, including ICU and ordinary
wards (item 4), and medication-related costs (item 20).
To compare the costs of the heart arrest CAB surgery
patients enrolled into clinical pathways with those not-
enrolled, Wilcoxon W testing showed that there was no
statistical significance in the costs across all individual
cost items (p>0.05).
To understand the effect of clinical pathways imple-
mented for heart arrest CAB surgery patients in costing
structures, we adjusting the patient personal and medical
characteristics into the cost modeling, including age,
gender, EuroSCORE and number of surgical graft bypass.
It was found that the heart arrest CAB surgery patients’
total costs were not relevant to the implementation of
clinical pathways (p>0.05, Table 3). However, lengths of
the postoperative ICU stays and ordinary ward stays were
positively related to CAB patients’ total costs (p<0.001,
Table 3).
Cost analysis for beating heart CAB surgery patients
Details of costs in the full course of disease treatment were
analyzed in patients received beating heart CAB surgery with
and without enrolled into the clinical pathway (i.e., Patient
Groups 3, 4, & 5) (Table 4). Overall, surgery-related costs,
including operation, anesthesia, and special medical materi-
als (items 16) were the largest costs in the beating heart CAB
surgery patients, followed by ward costs, including ICU and
ordinary wards (item 4), and medication-related costs (item
20). To compare the costs of the beating heart CAB surgery
patients, ANOVA analyses showed that beating heart CAB
surgery patients without enrolled in clinical pathways (i.e.,
Patient Group 5) had higher radiology costs than non-robotic
beating heart CAB surgery patients without enrolled clinical
pathways (i.e., Patient Group 3) (p<0.05). The treatment
costs, blood transfusion costs, and medication-related costs
were higher than robotic beating heart CAB surgery patients
with enrolled clinical pathways (i.e., Patient Group 4) (p<
0.05). However, beating heart CAB surgery patients without
enrolled in the clinical pathways (i.e., Patient Group 5) had
lower costs in examination and anesthesia than non-robotic
beating heart CAG surgery patients with enrolled clinical
pathways (i.e., Patient Group 3) and robotic beating heart
CAG surgery patients with enrolled clinical pathways (i.e.,
Patient Group 4), respectively (p<0.05).
To understand the effect of clinical pathways imple-
mented for beating heart CAB surgery patients in costing
structures, we adjusting the patient personal and medical
characteristics into the cost modeling, including age,
gender, EuroSCORE and number of surgical graft bypass.
It was found that the beating heart CAB surgery patients’
total costs were not relevant to the implementation of
clinical pathways (p>0.05, Table 5). However, complica-
tion occurrence and lengths of the post-operative ICU stays
and ordinary ward stays, were positively related to beating
heart CAB patients’ total costs (p<0.05, Table 5).
Effectiveness analysis for CAB surgery patients
The effectiveness measures for CAB surgery patients in this
study were complication occurrence and lengths of the
post-operative ICU stay and ordinary ward stay as
indicators. It was found that there was no significant
difference between the subgroups of patients with heart
arrest procedure and tri-groups of patients with beating
heart procedure (p>0.05) on the postoperative complication
indicator (Table 1). Furthermore, adjusting the patient
personal and medical characteristics, including age, gender,
EuroSCORE and number of surgical graft bypass, it was
found that the CAB surgery patients’ complication occur-
rence were not relevant to the implementation of clinical
pathways (Tables 3 and 5).
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Table 2 Costs comparisons for heart arrest CAB surgery patients with vs. without clinical pathways enrolled
Costs (US$) Total CP enrolled (n=25) Non-CP enrolled (n=23)
<Patient group 1> <Patient group 2>
Mean SD Mean SD Mean SD
1. Visiting 156.50 50.65 154.53 39.24 158.65 61.57
2. ICU wards 260.79 114.86 248.89 97.00 273.20 132.04
3. Ordinary wards 687.01 245.46 669.31 192.57 706.25 295.84
4. Sub-costs: wards (2.+3.) 942.36 356.91 908.24 293.04 979.45 419.16
5. Infusion and diets 24.13 10.31 25.08 10.81 21.62 10.45
6. General examination 687.79 186.87 635.19 136.10 744.97 218.71
7. Radiology 61.41 53.50 65.51 56.32 56.96 51.14
8. Sub-costs: examination (6.+7.) 749.21 212.94 700.69 155.47 801.94 254.79
9. General treatment 541.21 146.66 536.93 143.07 545.85 153.56
10. Infusion technique 78.44 38.09 76.31 27.12 80.75 47.82
11. Sub-costs: treatment (9.+10.) 619.65 175.50 613.24 163.49 626.61 191.16
12. Rehabilitation 112.03 59.60 113.07 49.97 110.85 70.18
13. Surgery 2,895.26 435.19 2,850.50 299.25 2,943.92 549.69
14. Anesthesia 1,043.32 229.78 1,075.06 231.28 1,008.82 228.15
15. Special medical materials 2,208.93 713.59 2,279.17 740.47 2,132.57 691.38
16. Sub-costs: surgery-related (13.+14.+15.) 6,147.51 1,083.18 6,204.73 828.63 6,085.32 1,322.77
17. Blood transfusion 379.72 228.84 337.43 179.59 425.69 269.16
18. Medication 860.07 378.23 860.99 366.57 859.08 398.80
19. Medication dispensing and management 33.62 10.66 33.60 7.64 33.64 13.38
20. Sub-costs: medication-related (18.+19.) 893.69 385.72 894.59 371.68 892.72 408.82
21. Total costs 10,003.86 1,928.40 9,934.54 1,417.75 10,079.21 2,395.92
Wilcoxon W testing for comparison patient group 1 vs. patient group 2 across all cost items. No statistical significances were found.
CP clinical pathway
Table 3 Outcome comparisons for heart arrest CAB surgery patients with vs. without clinical pathways enrolled (adjusted models)
Determinants Cost comparison Effectiveness comparison
Total costsa
(standardized β)
Complicationb
(odd ratio)
Postoperative ICU staya
(standardized β)
Postoperative ordinary ward
stayb (standardized β)
Enrolled clinical pathway
(default: no, patient group 2)
−0.02 0.97 −0.07 0.01
Age −0.24 0.97 −0.24 0.56*
Gender (default: female) 0.06 0.34 0.04 −0.10
EuroSCORE −0.04 1.13 0.43 −0.41
Number of surgical graft bypass −0.16 1.87 −0.05 0.11
Complication −0.17 – – –
Postoperative ICU stays (days) 0.53*** –
Postoperative ordinary ward
stay (days)
0.64*** –
*p<0.05; **p<0.01; ***p<0.001
aMultiple regression analysis
b Logistic regression analysis
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In terms of lengths of the postoperative ICU stay and
ordinary ward stay, we found that the implementation of
clinical pathways was not relevant to lengths of postoper-
ative stay (p>0.05, Table 3) in heart arrest CAB surgery
patients. However, heart arrest CAB surgery patients’ ages
played an important role in postoperative ordinary ward
stay (p<0.05, Table 3). On the other hand, robotic beating
heart CAB surgery patients enrolled clinical pathways
(Patient Group 4) were shown to have less postoperative
ordinary ward stay than those not enrolled clinical path-
ways (Patient Group 5) (p<0.001, Table 5). In addition, it
was found that beating heart CAB surgery patients with
higher surgical risks (measured as EuroSCORE) had higher
postoperative ICU stays (p<0.05, Table 5).
Discussion
With a retrospective study of 2003–2007, in this study, it
was found that there was differentiation across specified
Table 4 Costs comparisons for beating heart CAB surgery patients with vs. without clinical pathways enrolled
Cost (US$) Total CP enrolled NO CP enrolled ANOVA
Non-robotic Robotic
<Patient group 3> <Patient group 4> <Patient Group 5>
Mean SD Mean SD Mean SD Mean SD
1. Visiting 134.25 39.40 137.33 40.05 120.22 31.66 140.72 41.71 Group (5)>(4)*
2. ICU wards 214.63 105.06 202.33 100.29 201.86 85.19 237.45 119.83
3. Ordinary wards 583.56 193.17 593.37 195.02 524.80 150.98 614.10 210.87
4. Sub-costs: wards (2.+3.) 798.19 285.91 795.70 282.51 726.66 229.86 851.55 317.00
5. Infusion and diets 27.88 18.16 28.90 19.65 30.57 21.09 20.91 6.76
6. General examination 573.89 105.17 607.99 19.91 549.17 134.14 553.17 127.90 Group (3)>(4)**
Group (3)>(5)**
7. Radiology 71.75 59.72 43.80 1.35 106.05 68.81 78.82 71.33 Group (4)>(3)***
Group (5)>(3)***
8. Sub-costs: examination (6.+7.) 645.64 123.82 651.79 18.55 655.22 173.54 631.99 148.39
9. General treatment 479.56 112.23 502.11 119.65 425.77 99.53 492.31 100.83 Group (3)>(4)**
Group (5)>(4)*
10. Infusion technique 69.76 21.14 69.59 20.93 73.25 22.04 67.49 20.76
11. Sub-costs: treatment (9.+10.) 549.32 123.25 571.71 131.97 499.02 116.05 559.80 109.23 Group (3)>(4)*
Group (5)>(4)*
12. Rehabilitation 86.84 46.90 90.61 50.25 72.52 40.68 92.75 45.78
13. Surgery 2,254.68 159.60 2,276.29 112.86 2,280.17 118.77 2,212.43 214.07
14. Anesthesia 930.53 186.83 881.95 137.50 1,136.90 150.72 839.08 144.26 Group (4)>(3)***
Group (4)>(5)***
15. Special medical materials 1,799.08 787.20 1,709.77 806.65 1,648.60 791.44 2,005.53 730.19
16. Sub-costs: surgery-related (13.+14.+15.) 4,984.28 875.87 4,868.01 836.77 5,065.67 843.13 5,057.04 939.78
17. Blood transfusion 199.35 157.84 203.24 141.84 130.50 150.14 244.44 165.59 Group (5)>(4)**
18. Medication 695.35 235.73 788.48 243.10 558.08 168.40 688.02 221.71 Group (3)>(4)***
Group (3)>(5)*
Group (5)>(4)*
19. Medication dispensing and management 29.82 8.14 31.60 8.14 25.76 6.14 30.68 8.52 Group (3)>(4)***
Group (5)>(4)**
20. Sub-costs: medication-related (18.+19.) 725.16 239.77 820.08 246.67 583.84 170.43 718.69 225.87 Group (3)>(4)***
Group (3)>(5)*
Group (5)>(4)*
21. Total costs 8,142.13 1,335.02 8,149.62 1,318.94 7,859.61 1,199.97 8,333.44 1,427.67
CP clinical pathway
*p<0.05; **p<0.01; ***p<0.001
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cost items in beating heart CAB surgery patients, but not
for heart arrest CAB surgery patients with and without
clinical pathways enrolled. In addition, there was no
difference in postoperative complication occurrence in
CAB surgery patients enrolled into clinical pathways.
However, robotic beating heart CAB surgery patients
enrolled clinical pathways (Patient Group 4) were shown
to have less postoperative ordinary ward stay than those not
enrolled clinical pathways (Patient Group 5). CAB surgery
patients’ age and surgical risk (EuroSCORE) were related
to their postoperative lengths of stay to some extent.
Because of different surgical procedures, which make
different results in short term or long term outcomes, the
data are separated into two major groups: those who
received heart arrest CAB surgery and those who received
beating heart CAB surgery to compare the effect of clinical
pathway and non-clinical pathway. However, smaller case
number in patients who received heart arrest CAB surgery
might exist fewer heterogeneity in the data and in turns,
might deter to identify the statistical relationships in cost
and effectiveness with or without the implementation of
clinical pathways. On the other hand, it was found that
various cost portraits in beating heart CAB surgery patients
with and without enrolled into clinical pathways. The one-
by-one cost investigation could make the medical profes-
sionals to understand the detailed resources utilized. The
clinical pathway contains multidisciplinary plans that
outline the sequence and timing of actions necessary to
achieve expected patient outcomes with optimal efficiency.
The impact of clinical pathways is greatly influenced by the
pathway development and implementation process. It
suggests that the CAB surgery multidisciplinary team could
re-examine the care processes to identify the causes of
resource utilization and better surgical techniques. For
example, robotic beating heart CAB surgery has been
budding in recent 5 years and it was introduced in this
studied medical center in the past 2 years. It might be the
reason why it costs more for anesthesia; in other words, more
surgical time is demanded. However, prolonged surgical time
does not seem to affect the length of ordinary ward stay in the
studied patients and the cost of robotic CAB surgery was still
less than the traditional beating heart surgery. It’s reasonable
to presume that robotic CAB surgery makes a greater
difference in traditional beating heart surgery if robotic
procedures are matured in the future.
Some studies pointed out that CAB surgery patients with
shorter ICU stay begin ambulation sooner and in turn,
reduced the risk of postoperative complication as well as
cost [26], and verified that short-stay intensive care is a safe
and cost-effective approach for low-risk CAB surgery
patients [27]. In this study, there were no difference in the
ICU length of stay between/among clinical pathway and
non-clinical pathway groups; however, we found that
length of ordinary ward stay exist larger variety, which
were related to clinical pathway enrolled for beating heart
CAB surgery patients and elder heart arrest CAB surgery
patients. It might be the timing for the medical professio-
nals in the studied medical center to explore the possible
causes or mechanisms which driven the higher utilization of
length of ordinary ward stay in the CAB postoperative
stage. Furthermore, the lengths of ICU and hospital stay are
closely relative to the time for tracheal extubation [28]. We
Table 5 Outcome comparisons for beating heart CAB surgery patients with vs. without clinical pathways enrolled (adjusted models)
Determinants Cost comparison Effectiveness comparison
Total costsa
(standardized β)
Complicationb
(odd ratio)
Postoperative ICU staya
(standardized β)
Postoperative ordinary ward
staya (standardized β)
Enrolled clinical pathway (default: no
enrolled <patient group 5>)
Clinical pathway enrolled
robotic <patient group 4>
0.00 0.50 −0.07 −0.43***
Clinical pathway enrolled
non-robotic <patient group 3>
0.01 0.37 −0.10 −0.10
Age −0.04 1.08 −0.01 0.14
Gender (default: female) 0.07 0.49 −0.03 0.04
EuroSCORE 0.06 1.35 0.25* 0.05
Number of surgical graft bypass 0.09 0.61 0.08 −0.09
Complication 0.47*** – – –
Postoperative ICU stays (days) 0.23** – – –
Postoperative ordinary ward stay (days) 0.14* – – –
*p<0.05; **p<0.01; ***p<0.001
aMultiple regression analysis
b Logistic regression analysis
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could try to reduce the postoperative intubation time by
effort and then shorten the hospital stay.
There are several limitations in this study. The first is
that well documented data was available for only 5 years
and it leads to smaller case number in patients who received
traditional heart arrest CAB surgery, which may be the
reason for the effective verification of the effect of clinical
pathways. Furthermore, the exclusive criteria in this study
were made by Bureau of National Health Insurance in
Taiwan also led to smaller sample size to be enrolled into
the clinical pathway and it might dissemble the reality of
clinical pathway administration.
Second, EuroSCORE was used to evaluate cardiac
surgery patients for risk factors. Another indicator for
short-term outcomes such as in-hospital mortality and
prolonged length of stay for CAB surgery patients [29]
might be used for risk stratification in the future. Further-
more, failures to account for the length of stay in the
rehabilitation of health care facilities or at homes [30, 31]
might be one limitation in our retrospective study.
Another limitation was that the details of the clinical
pathway are revised annually in the studied medical center.
These might lead to the changed contents of clinical
pathways and changing medical professional behaviors
annually. Or variance from the clinical pathway might be
decreased significantly after continued implementation
[32]. In addition to implementing the pathway itself,
education process accompanying pathway adoption is also
a key for the value of pathways and it argued that clinical
pathways could improve patient quality of care even if they
do not reduce the length of stay [32]. The trend in this study
might provide substantial insights and more clinical
outcome indicators such as morbidity, mortality rate,
readmission rate [33], quality of life indicators such as
patient comfort of post-operation, and medical professional
management and team approach issues should be included
to ensure quality improvement, rather than cost reduction
[12, 34, 35] in the future. Furthermore, clinical benchmark-
ing could be learned from the peers in other countries to
improve clinical pathways with CAB surgery in the future.
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Appendix 1 Design of clinical pathway for coronary
artery bypass surgery in the studied medical center
Part I. Preoperative preparation
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Part II. Operation and postoperative pathway
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Appendix 2 Criteria excluded from clinical pathways
for CAB surgery patients proposed by Bureau of
National Health Insurance
Infection diseases
1. Septicemia
2. Perioperative pneumonia
3. Meningitis
4. Tuberculous disorders
5. Viral hepatitis B with hepatic coma
6. Candidiasis
Renal diseases
1. Acute renal failure
Lung diseases
1. Pulmonary embolism
Neural diseases
1. Cerebral infarction
2. Diabetes with hyperosmolar coma
Cardiovascular diseases
1. Acute and subacute bacterial endocarditis
2. Postoperative acute myocardial infarction
3. Aortic dissection
4. Preoperative cardiogenic shock
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